Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses

Krystyna M. Jones, Lilja Solnes, Steven Rowe, Michael Gorin, Sara Sheikhbahaei, George Fung, Eric Frey, Mohamad E Allaf, Yong Du, Mehrbod Som Som Javadi

Research output: Contribution to journalArticle

Abstract

Objective: Technetium-99m (99mTc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) has previously been shown to allow for the accurate differentiation of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors (HOCTs) apart from other malignant renal tumor histologies, with oncocytomas/HOCTs showing high uptake and renal cell carcinoma (RCC) showing low uptake based on uptake ratios from non-quantitative single-photon emission computed tomography (SPECT) reconstructions. However, in this study, several tumors fell close to the uptake ratio cutoff, likely due to limitations in conventional SPECT/CT reconstruction methods. We hypothesized that application of quantitative SPECT/CT (QSPECT) reconstruction methods developed by our group would provide more robust separation of hot and cold lesions, serving as an imaging framework on which quantitative biomarkers can be validated for evaluation of renal masses with 99mTc-sestamibi. Methods: Single-photon emission computed tomography data were reconstructed using the clinical Flash 3D reconstruction and QSPECT methods. Two blinded readers then characterized each tumor as hot or cold. Semi-quantitative uptake ratios were calculated by dividing lesion activity by background renal activity for both Flash 3D and QSPECT reconstructions. Results: The difference between median (mean) hot and cold tumor uptake ratios measured 0.655 (0.73) with the QSPECT method and 0.624 (0.67) with the conventional method, resulting in increased separation between hot and cold tumors. Sub-analysis of 7 lesions near the separation point showed a higher absolute difference (0.16) between QPSECT and Flash 3D mean uptake ratios compared to the remaining lesions. Conclusions: Our finding of improved separation between uptake ratios of hot and cold lesions using QSPECT reconstruction lays the foundation for additional quantitative SPECT techniques such as SPECT-UV in the setting of renal 99mTc-sestamibi and other SPECT/CT exams. With robust quantitative image reconstruction and biomarker analysis, there may be an expanded role for SPECT/CT imaging in renal masses and other pathologic conditions.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalAnnals of Nuclear Medicine
DOIs
StateAccepted/In press - Dec 6 2017

Fingerprint

Technetium Tc 99m Sestamibi
Kidney
Single-Photon Emission-Computed Tomography
Neoplasms
Biomarkers
Oxyphilic Adenoma
Single Photon Emission Computed Tomography Computed Tomography
Computer-Assisted Image Processing
Renal Cell Carcinoma
Histology

Keywords

  • Oncocytoma
  • Quantitative
  • RCC
  • Sestamibi
  • SPECT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses. / Jones, Krystyna M.; Solnes, Lilja; Rowe, Steven; Gorin, Michael; Sheikhbahaei, Sara; Fung, George; Frey, Eric; Allaf, Mohamad E; Du, Yong; Javadi, Mehrbod Som Som.

In: Annals of Nuclear Medicine, 06.12.2017, p. 1-7.

Research output: Contribution to journalArticle

@article{9cebe4b9c9c54fc5bc1b120c1f90e0ad,
title = "Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses",
abstract = "Objective: Technetium-99m (99mTc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) has previously been shown to allow for the accurate differentiation of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors (HOCTs) apart from other malignant renal tumor histologies, with oncocytomas/HOCTs showing high uptake and renal cell carcinoma (RCC) showing low uptake based on uptake ratios from non-quantitative single-photon emission computed tomography (SPECT) reconstructions. However, in this study, several tumors fell close to the uptake ratio cutoff, likely due to limitations in conventional SPECT/CT reconstruction methods. We hypothesized that application of quantitative SPECT/CT (QSPECT) reconstruction methods developed by our group would provide more robust separation of hot and cold lesions, serving as an imaging framework on which quantitative biomarkers can be validated for evaluation of renal masses with 99mTc-sestamibi. Methods: Single-photon emission computed tomography data were reconstructed using the clinical Flash 3D reconstruction and QSPECT methods. Two blinded readers then characterized each tumor as hot or cold. Semi-quantitative uptake ratios were calculated by dividing lesion activity by background renal activity for both Flash 3D and QSPECT reconstructions. Results: The difference between median (mean) hot and cold tumor uptake ratios measured 0.655 (0.73) with the QSPECT method and 0.624 (0.67) with the conventional method, resulting in increased separation between hot and cold tumors. Sub-analysis of 7 lesions near the separation point showed a higher absolute difference (0.16) between QPSECT and Flash 3D mean uptake ratios compared to the remaining lesions. Conclusions: Our finding of improved separation between uptake ratios of hot and cold lesions using QSPECT reconstruction lays the foundation for additional quantitative SPECT techniques such as SPECT-UV in the setting of renal 99mTc-sestamibi and other SPECT/CT exams. With robust quantitative image reconstruction and biomarker analysis, there may be an expanded role for SPECT/CT imaging in renal masses and other pathologic conditions.",
keywords = "Oncocytoma, Quantitative, RCC, Sestamibi, SPECT",
author = "Jones, {Krystyna M.} and Lilja Solnes and Steven Rowe and Michael Gorin and Sara Sheikhbahaei and George Fung and Eric Frey and Allaf, {Mohamad E} and Yong Du and Javadi, {Mehrbod Som Som}",
year = "2017",
month = "12",
day = "6",
doi = "10.1007/s12149-017-1222-z",
language = "English (US)",
pages = "1--7",
journal = "Annals of Nuclear Medicine",
issn = "0914-7187",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses

AU - Jones, Krystyna M.

AU - Solnes, Lilja

AU - Rowe, Steven

AU - Gorin, Michael

AU - Sheikhbahaei, Sara

AU - Fung, George

AU - Frey, Eric

AU - Allaf, Mohamad E

AU - Du, Yong

AU - Javadi, Mehrbod Som Som

PY - 2017/12/6

Y1 - 2017/12/6

N2 - Objective: Technetium-99m (99mTc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) has previously been shown to allow for the accurate differentiation of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors (HOCTs) apart from other malignant renal tumor histologies, with oncocytomas/HOCTs showing high uptake and renal cell carcinoma (RCC) showing low uptake based on uptake ratios from non-quantitative single-photon emission computed tomography (SPECT) reconstructions. However, in this study, several tumors fell close to the uptake ratio cutoff, likely due to limitations in conventional SPECT/CT reconstruction methods. We hypothesized that application of quantitative SPECT/CT (QSPECT) reconstruction methods developed by our group would provide more robust separation of hot and cold lesions, serving as an imaging framework on which quantitative biomarkers can be validated for evaluation of renal masses with 99mTc-sestamibi. Methods: Single-photon emission computed tomography data were reconstructed using the clinical Flash 3D reconstruction and QSPECT methods. Two blinded readers then characterized each tumor as hot or cold. Semi-quantitative uptake ratios were calculated by dividing lesion activity by background renal activity for both Flash 3D and QSPECT reconstructions. Results: The difference between median (mean) hot and cold tumor uptake ratios measured 0.655 (0.73) with the QSPECT method and 0.624 (0.67) with the conventional method, resulting in increased separation between hot and cold tumors. Sub-analysis of 7 lesions near the separation point showed a higher absolute difference (0.16) between QPSECT and Flash 3D mean uptake ratios compared to the remaining lesions. Conclusions: Our finding of improved separation between uptake ratios of hot and cold lesions using QSPECT reconstruction lays the foundation for additional quantitative SPECT techniques such as SPECT-UV in the setting of renal 99mTc-sestamibi and other SPECT/CT exams. With robust quantitative image reconstruction and biomarker analysis, there may be an expanded role for SPECT/CT imaging in renal masses and other pathologic conditions.

AB - Objective: Technetium-99m (99mTc)-sestamibi single-photon emission computed tomography/computed tomography (SPECT/CT) has previously been shown to allow for the accurate differentiation of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors (HOCTs) apart from other malignant renal tumor histologies, with oncocytomas/HOCTs showing high uptake and renal cell carcinoma (RCC) showing low uptake based on uptake ratios from non-quantitative single-photon emission computed tomography (SPECT) reconstructions. However, in this study, several tumors fell close to the uptake ratio cutoff, likely due to limitations in conventional SPECT/CT reconstruction methods. We hypothesized that application of quantitative SPECT/CT (QSPECT) reconstruction methods developed by our group would provide more robust separation of hot and cold lesions, serving as an imaging framework on which quantitative biomarkers can be validated for evaluation of renal masses with 99mTc-sestamibi. Methods: Single-photon emission computed tomography data were reconstructed using the clinical Flash 3D reconstruction and QSPECT methods. Two blinded readers then characterized each tumor as hot or cold. Semi-quantitative uptake ratios were calculated by dividing lesion activity by background renal activity for both Flash 3D and QSPECT reconstructions. Results: The difference between median (mean) hot and cold tumor uptake ratios measured 0.655 (0.73) with the QSPECT method and 0.624 (0.67) with the conventional method, resulting in increased separation between hot and cold tumors. Sub-analysis of 7 lesions near the separation point showed a higher absolute difference (0.16) between QPSECT and Flash 3D mean uptake ratios compared to the remaining lesions. Conclusions: Our finding of improved separation between uptake ratios of hot and cold lesions using QSPECT reconstruction lays the foundation for additional quantitative SPECT techniques such as SPECT-UV in the setting of renal 99mTc-sestamibi and other SPECT/CT exams. With robust quantitative image reconstruction and biomarker analysis, there may be an expanded role for SPECT/CT imaging in renal masses and other pathologic conditions.

KW - Oncocytoma

KW - Quantitative

KW - RCC

KW - Sestamibi

KW - SPECT

UR - http://www.scopus.com/inward/record.url?scp=85037088572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037088572&partnerID=8YFLogxK

U2 - 10.1007/s12149-017-1222-z

DO - 10.1007/s12149-017-1222-z

M3 - Article

SP - 1

EP - 7

JO - Annals of Nuclear Medicine

JF - Annals of Nuclear Medicine

SN - 0914-7187

ER -